These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24640614)

  • 1. FDA's evolving approach to nanotechnology.
    Monica JC
    Food Drug Law J; 2012; 67(4):405-11, i. PubMed ID: 24640614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Science and regulation. FDA's approach to regulation of products of nanotechnology.
    Hamburg MA
    Science; 2012 Apr; 336(6079):299-300. PubMed ID: 22517845
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond biotechnology: FDA regulation of nanomedicine.
    Miller J
    Columbia Sci Technol Law Rev; 2003; 4():E5. PubMed ID: 15977335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA to steer nanotech.
    Fox JL
    Nat Biotechnol; 2008 Oct; 26(10):1060. PubMed ID: 18846060
    [No Abstract]   [Full Text] [Related]  

  • 7. Further amendments to general regulations of the Food and Drug Administration to incorporate tobacco products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Feb; 77(22):5171-6. PubMed ID: 22359802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amendments to general regulations of the Food and Drug Administration. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Nov; 75(229):73951-5. PubMed ID: 21121182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food after Fukushima--Japan's regulatory response to the radioactive contamination of its food chain.
    Berends G; Kobayashi M
    Food Drug Law J; 2012; 67(1):51-64, i-ii. PubMed ID: 24624648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informal guidance and the FDA.
    Lewis KM
    Food Drug Law J; 2011; 66(4):507-50, i. PubMed ID: 24505827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating (for the benefit of) future persons: a different perspective on the FDA's jurisdiction to regulate human reproductive cloning.
    Javitt GH; Hudson K
    Utah Law Rev; 2003; 2003(4):1201-29. PubMed ID: 15622618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Information to Improve Public Perceptions of the Food and Drug Administration (FDA's) Tobacco Regulatory Role.
    Osman A; Kowitt SD; Sheeran P; Jarman KL; Ranney LM; Goldstein AO
    Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29661991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Under the law, FDA must grant different standards for new dietary ingredients and food additives.
    Mister S; Hathcock J
    Regul Toxicol Pharmacol; 2012 Apr; 62(3):456-8. PubMed ID: 22310217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulating nanomedicine - can the FDA handle it?
    Bawa R
    Curr Drug Deliv; 2011 May; 8(3):227-34. PubMed ID: 21291376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of FDA warning letters and notices of violation issued for patient-reported outcomes promotional claims between 2006 and 2012.
    Symonds T; Hackford C; Abraham L
    Value Health; 2014 Jun; 17(4):433-7. PubMed ID: 24969004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidance of FDA's expectations of medical device manufacturers concerning the year 2000 date problem--FDA. Notice.
    Fed Regist; 1998 Jun; 63(121):34433-42. PubMed ID: 10180297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of US EPA and FDA requirements for electronic records, electronic signatures, and electronic submissions.
    Keatley KL
    Qual Assur; 1999; 7(2):77-89. PubMed ID: 10992873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
    Harapanhalli RS
    Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical device data systems and FDA regulation. Should medical device data systems require FDA clearance?
    Kelley P
    J Healthc Inf Manag; 2010; 24(3):36-40. PubMed ID: 20677470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.